BRUNO, ANTONINO
 Distribuzione geografica
Continente #
NA - Nord America 9.985
EU - Europa 5.680
AS - Asia 4.019
SA - Sud America 504
Continente sconosciuto - Info sul continente non disponibili 354
AF - Africa 87
OC - Oceania 20
Totale 20.649
Nazione #
US - Stati Uniti d'America 9.760
IT - Italia 3.014
SG - Singapore 1.396
CN - Cina 874
VN - Vietnam 490
HK - Hong Kong 481
UA - Ucraina 435
BR - Brasile 406
DE - Germania 404
SE - Svezia 404
GB - Regno Unito 255
TR - Turchia 252
FR - Francia 249
IE - Irlanda 220
FI - Finlandia 196
RU - Federazione Russa 153
BD - Bangladesh 144
CA - Canada 117
IN - India 102
JP - Giappone 78
MX - Messico 70
NL - Olanda 67
ES - Italia 50
PL - Polonia 48
AR - Argentina 38
ZA - Sudafrica 34
AT - Austria 32
BE - Belgio 29
CZ - Repubblica Ceca 29
IQ - Iraq 25
ID - Indonesia 21
CH - Svizzera 19
MY - Malesia 19
LT - Lituania 18
NG - Nigeria 16
AU - Australia 15
PK - Pakistan 15
EC - Ecuador 14
TH - Thailandia 14
CL - Cile 11
CO - Colombia 11
EU - Europa 11
KR - Corea 11
SA - Arabia Saudita 11
IR - Iran 10
PH - Filippine 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
TN - Tunisia 8
UZ - Uzbekistan 8
IL - Israele 7
MA - Marocco 7
PY - Paraguay 7
RO - Romania 7
TW - Taiwan 7
GR - Grecia 6
JM - Giamaica 6
KE - Kenya 6
MD - Moldavia 6
CR - Costa Rica 5
DK - Danimarca 5
DZ - Algeria 5
EG - Egitto 5
HN - Honduras 5
NP - Nepal 5
NZ - Nuova Zelanda 5
AZ - Azerbaigian 4
HU - Ungheria 4
NO - Norvegia 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BG - Bulgaria 3
IS - Islanda 3
JO - Giordania 3
KZ - Kazakistan 3
OM - Oman 3
PR - Porto Rico 3
BF - Burkina Faso 2
BZ - Belize 2
EE - Estonia 2
GT - Guatemala 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
MC - Monaco 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
Totale 20.289
Città #
Milan 1.648
San Jose 922
Ashburn 905
Singapore 845
Fairfield 647
Chandler 559
Woodbridge 547
Hong Kong 469
Houston 431
Council Bluffs 370
Jacksonville 357
Dallas 344
Ann Arbor 315
Seattle 273
Beijing 267
Wilmington 235
Como 233
Cambridge 224
Los Angeles 223
Dublin 215
The Dalles 210
Boardman 181
Nyköping 179
Princeton 175
New York 163
Chicago 162
Rome 146
Dearborn 124
Lauterbourg 121
Izmir 110
Ho Chi Minh City 100
Santa Clara 95
Dong Ket 91
Hanoi 87
Munich 85
London 82
Helsinki 72
Varese 72
Buffalo 67
São Paulo 62
Tokyo 55
San Diego 53
Orem 45
Turku 45
Washington 43
Frankfurt am Main 42
Mexico City 42
Warsaw 41
Denver 39
Montreal 39
Salt Lake City 38
Des Moines 35
Stockholm 35
Brooklyn 34
Nuremberg 31
Guangzhou 29
Manchester 29
Ogden 29
Brussels 28
Johannesburg 27
Shanghai 27
Atlanta 26
Gallarate 26
San Francisco 26
Brno 25
Chennai 25
Elk Grove Village 25
Phoenix 24
Poplar 24
Amsterdam 23
Toronto 23
Boston 20
Vienna 20
Düsseldorf 19
Kocaeli 19
Magnago 16
Tampa 16
Hefei 14
Abuja 13
Cantù 13
Genoa 13
Palermo 13
Verona 13
Da Nang 12
Kunming 12
Las Vegas 12
Tianjin 12
Basingstoke 11
Berlin 11
Cavaria con Premezzo 11
Charlotte 11
Jinan 11
Monza 11
Moscow 11
Norwalk 11
Pittsburgh 11
Pune 11
San Mateo 11
Turin 11
Ankara 10
Totale 13.825
Nome #
Polarization of Tumor Infiltrating Leukocytes from Innate Immunity and their role in the Pro-angiogenic Phenotype in NSCLC 311
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer 308
Natural killer cells from patients with malignant or inflammatory pleural effusions display decreased cytotoxicity and decidual NK-like phenotype 287
Myeloid derived suppressor cells interactions with natural killer cells and pro-angiogenic activities: roles in tumor progression 274
Environmental impact of multi-wall carbon nanotubes in a novel model of exposure: Systemic distribution, macrophage accumulation, and amyloid deposition 270
Cancer stem cells and the tumor microenvironment: Interplay in tumor heterogeneity 256
Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders? 256
Proline Dehydrogenase affects lung cancer cell proliferation by inducing ROS and cellular senescence 254
A think tank of TINK/TANKs: Tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis 250
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies 244
Biomarkers of cancer angioprevention for clinical studies 239
Potential chemopreventive activities of a polyphenol rich purified extract from olive mill wastewater on colon cancer cells 237
Cardiovascular active peptides of marine origin with ACE inhibitory activities: Potential role as anti-hypertensive drugs and in prevention of SARSCoV-2 infection 237
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization 235
Natural killer cells from patients with either malignant or inflammatory pleural effusions display decreased cytotoxic capacity and decidual-like phenotype 229
Effect of a Purified Extract of Olive Mill Waste Water on Endothelial Cell Proliferation, Apoptosis, Migration and Capillary-Like Structure in vitro and in vivo. 225
Natural killer cells as key players of tumor progression and angiogenesis: old and novel tools to divert their pro-tumor activities into potent anti-tumor effects 225
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways 224
Unravelling the role of proline dehydrogenase (PRODH) in lung adenocarcinoma: implications for cellular senescence and the tumor microenvironment 222
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer 220
Systemic distribution of single-walled carbon nanotubes in a novel model: alteration of biochemical parameters, metabolic functions, liver accumulation, and inflammation in vivo 218
Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues 217
Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ros production in endothelial cells and cardiomyocytes 211
SANIST: optimization of a technology for compound identification based on the European Union directive with applications in forensic, pharmaceutical and food analyses 210
Proffered Paper: The pro-angiogenic phenotype of natural killer cells infiltrating squamous cell carcinoma lung cancer 209
Inflammatory angiogenesis and the tumor microenvironment as targets for cancer therapy and prevention 208
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment 206
Orchestration of angiogenesis by immune cells 203
Fenretinide (4-HPR) targets caspase-9, ERK 1/2 and the Wnt3a/β-catenin pathway in medulloblastoma cells and medulloblastoma cell spheroids 200
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors 197
SANIST: A rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers 195
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy 195
Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy 193
The pro-angiogenic phenotype and functions of colorectal cancer tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells 192
Paradoxic effects of metformin on endothelial cells and angiogenesis. 187
Tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells: a new paradigm in colorectal cancer angiogenesis 185
Proline Dehydrogenase as a player in acquired resistance to Tyrosine Kinase Inhibitors 179
The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic effectors 176
The Angiogenic Switch: Role of Immune Cells 174
Mutant alleles in Aicardi-Goutieres syndrome patients produce a disfunctional RNASET2 protein associated with alterations in interferon signalling. 173
Natural killer cells from pleural effusions are responsive to interleukin-2 but are endowed with a potent pro-angiogenic feature 173
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment 173
Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation 170
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation 170
A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease 168
Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis 167
Natural killer cells from malignant pleural effusion show a decidual-like phenotype and an alternative activatory state. 162
Prostate cancer peripheral blood NK cells show enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 production, and secrete monocyte-recruiting and polarizing factors. 161
MiR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2 160
Natural killer cells infiltrating colo-rectal cancer are switched towards the decidual-like pro-angiogenic CD56brightCD16- NK cell subset 159
Pleural effusion NK cells from metastatic tumors display pro-angiogenic features and pleural effusion fluids block their response to IL-2 treatment 156
Downregulation of pro-inflammatory and pro-angiogenic pathways in prostate cancer cells by a polyphenol-rich extract from olive mill wastewater 154
STAT3 and STAT5 drive the pro-angiogenic NK cell polarization in colorectal cancer patients 153
Tumor infiltrating (TINKs) and tumor associated (TANKs) from colorectal cancer patients are proangiogenic and express angiogenin and the MMP9-TIMP2, similar to decidual NK cells 153
The human RNASET2 alarmin-like molecule differentially affects prostate cancer cells behavior in both cell autonomous and non-cell autonomous manners 152
Innate immunity driving tumor angiogenesis: the role of natural killer cells in non-small cell lung cancer (NSCLC) 151
Subcapsular sinus macrophages promote melanoma metastasis to the sentinel lymph nodes via an IL-1α-STAT3 axis 149
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients 148
Nutraceuticals and “repurposed” drugs of phytochemical origin in prevention and interception of chronic degenerative diseases and cancer 147
When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors 147
Microalgal derivatives as potential nutraceutical and food supplements for human health: A focus on cancer prevention and interception 146
Phenotypic and functional characterization of tumor infiltrating natural killer cells: role in tumor angiogenesis 145
Functional and phenotypic characterization of tumor infiltrating NK cells. 144
Adipose mesenchymal stem cell-derived soluble factors, produced under hypoxic condition, efficiently support in vivo angiogenesis 141
The NK cells phenotype and function in resected non small cell lung cancer: differences between squamous and adenocarcinoma. 141
Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher 140
The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors 139
Tumor-infiltrating (TINKs) and tumor-associated (TANKs) natural killer cells: a new player in the inflammatory orchestration of tumor angiogenesis in colon cancer 139
Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis 139
Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer Pathogenesis 138
Circulating and tumor infiltrating natural killer cells in renal cancer patients express the CD9 and CD49a decidual markers and have increased activation of STAT3 137
The Pharmacologist’s Point of View: Mechanisms of Cardiotoxicity 137
Phenotypic and functional characterization of tumor infiltrating natural killer cells: role in tumor angiogenesis 136
VEGFR2 and CXCR4 pathways are modulated by acetyl-l-Carnitine that acts as an anti-angiogenic agent 136
The role of tumor infiltrating and tumor associated natural killer cells in promotion of angiogenesis in colorectal cancer patients 135
Natural killer cells from malignant pleural effusion are switched toward an NK proangiogenic polarization 135
Proline Dehydrogenase (PRODH) Is Expressed in Lung Adenocarcinoma and Modulates Cell Survival and 3D Growth by Inducing Cellular Senescence 134
Functional and phenotypic characterization of tumor infiltrating NK cells to identify novel targets for anticancer therapy. 134
Human Dental Pulp Mesenchymal Stem Cell-Derived Soluble Factors Combined with a Nanostructured Scaffold Support theGeneratio of a Vascular Network In Vivo 133
Innate immunity driving tumor angiogenesis: the role of natural killer cells in non small cell lung cancer (NSCLC) 133
Prostate cancer associated natural killer cells show a pro-angiogenic and pro-inflammatory phenotype. 133
A Polyphenol-Rich Extract of Olive Mill Wastewater Enhances Cancer Chemotherapy Effects, While Mitigating Cardiac Toxicity 132
NK cells-modulation of tumor angiogenesis. 130
NK cells as modulators of tumor angiogenesis 129
Natural compounds of marine origin as inducers of immunogenic cell death (ICD): potential role for cancer interception and therapy 129
Metabolic Rewiring in the Tumor Microenvironment to Support Immunotherapy: A Focus on Neutrophils, Polymorphonuclear Myeloid-Derived Suppressor Cells and Natural Killer Cells 129
The role of natural killer cells in lung cancer angiogenesis 128
An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity 127
Serum steroid ratio profiles in prostate cancer: A new diagnostic tool toward a personalized medicine approach 127
The cell-autonomous and non-cell autonomous activities of the alarmin-like RNASET2 protein in prostate cancer models 126
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity 125
A PSA-guided approach for a better diagnosis of prostatic adenocarcinoma based on MALDI profiling and peptide identification 124
Dental pulp mesenchymal stem cell (DPSCs)-derived soluble factors, produced under hypoxic conditions, support angiogenesis via endothelial cell activation and generation of M2-like macrophages 119
Use of extract of vegetation waters in the regeneration of epithelial tissue 116
TIMP1 and TIMP2 downregulate TGFβ induced decidual-like phenotype in natural killer cells 113
Proline Dehydrogenase as new marker and target in EGFR mutant Non-Small Cell Lung carcinoma 111
The Dual Role of Natural Killer Cells During Tumor Progression and Angiogenesis: Implications for Tumor Microenvironment-targeted Immunotherapies. 108
Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory 105
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 104
Natural Killer Cells in Graves’ Disease: Increased Frequency but Impaired Degranulation Ability Compared to Healthy Controls 104
Totale 17.285
Categoria #
all - tutte 86.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.054


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022817 0 0 21 27 56 51 60 61 174 173 63 131
2022/20231.624 143 105 114 208 116 324 7 204 189 75 76 63
2023/20242.837 382 390 379 511 580 198 23 60 55 115 14 130
2024/20252.832 47 32 345 146 216 146 135 147 315 412 314 577
2025/20266.890 466 385 427 951 777 332 1.224 453 639 529 389 318
2026/2027812 232 374 206 0 0 0 0 0 0 0 0 0
Totale 20.649